Cuorips (4894) · FactAdvanced
Listing on the Tokyo Stock Exchange Growth Market and Public Offering
First written in FY2023. 1 of 2 entries say "Advanced", first in FY2024-Q1. Latest entry: FY2024-Q1.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Tokyo Stock Exchange Mothers/Growth Market Listing and Growth and Talent Investment Through a Public OfferingA theme 268 companies write about · 0 as a headwind · 272 as a tailwind
The whole theme swung hardest in 2022: 23 of 90 companies on the "Worse" side.
28 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 273 threads.Full recordFilings, disclosures and news, newest first
- FY2024-Q1AdvancedAnnual report
「We listed our shares on the Tokyo Stock Exchange Growth Market on 27 June 2023. In connection with the listing, at meetings of the Board of Directors held on 23 May and 8 June 2023, we resolved to issue new shares through a private placement to Nomura Securities Co., Ltd., the allottee, in connection with its over-allotment offering. Payment was completed on 25 July 2023.」
In addition to the public offering accompanying the listing, payment was completed on 25 July 2023 for a private placement of 293,800 shares in connection with the over-allotment offering, totaling ¥421.661 million. The proceeds were for working capital and capital investment. - FY2023First statedAnnual report
「Our shares were listed on the Tokyo Stock Exchange Growth Market on 27 June 2023.」
In connection with the June 2023 listing, the company issued 1,700,000 shares through a public offering. The proceeds were to be used for research and development expenses and construction of cell-culture processing facilities.